Advanced Biomed Inc. ADVB
1.75 USD -0.40 (-18.79%)
Regular-session close
1.75 0.00 0.00%
After hours · Nov 19, 5:29 PM ET
1.70 Day range 2.15
1.70 52-week range 24.23
- YTD
- -70.03%
- 1 year
- -78.81%
News
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers Milestone Scientific (AMEX:MLSS) stock moved upwards by 19.5% to $0.36 during Friday's pre-market session. The company's market cap stands at $27.1 million. Eton Pharmaceuticals (NASDAQ:ETON)…
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Tempest Therapeutics (NASDAQ:TPST) stock rose 8.9% to $0.57 during Wednesday's after-market session. The market value of their outstanding shares is at $10.1 million. Tenax Therapeutics…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Pharvaris (NASDAQ:PHVS) stock moved upwards by 19.4% to $36.9 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.0 billion. CalciMedica (NASDAQ:CALC)…
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session Gainers Silence Therapeutics (NASDAQ:SLN) stock increased by 125.6% to $19.59 during Monday's regular session. The market value of their outstanding shares is at $581.1 million. SCWorx (NASDAQ:WORX)…
defenseworld.net Advanced Biomed (NASDAQ:ADVB) and Sphere 3D (NASDAQ:ANY) Financial Review Advanced Biomed (NASDAQ: ADVB - Get Free Report) and Sphere 3D (NASDAQ: ANY - Get Free Report) are both small-cap technology companies, but which is the superior business? We will contrast the two…defenseworld.net Advanced Biomed Inc. (NASDAQ:ADVB) Shares Shorted: Short Interest Down 39.8% in September Advanced Biomed Inc. (NASDAQ: ADVB - Get Free Report) was the target of a significant drop in short interest in September. As of September 15th, there was short interest totaling 9,845 shares, a drop…
globenewswire.com Advanced Biomed Inc. Announces 1 for 20 Share Consolidation Tainan City, Taiwan, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (Nasdaq: ADVB) (the “Company” or “Advanced Biomed”), a biotechnology company focused on developing and commercializing…
globenewswire.com Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery Tainan, Taiwan, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (Nasdaq: ADVB) (the “Company”, “Advanced Biomed”), a biotechnology company focused on developing and commercializing innovative…
globenewswire.com Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary Tainan City, Taiwan, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (Nasdaq: ADVB) (the “Company”, “Advanced Biomed”), a biotechnology company focused on developing and commercializing…
globenewswire.com Advanced Biomed Inc. Announces Launch of A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery [Tainan City], Taiwan, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (Nasdaq: ADVB) (the “Company”, “Advanced Biomed”), a biotechnology company focused on developing and commercializing…
globenewswire.com Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering Tainan, Taiwan, March 07, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (the "Company") (NASDAQ: ADVB), a biotechnology company focused on early screening and detection, diagnosis and staging, and…
seekingalpha.com IPO Update: Advanced Biomed Finalizes $112 Million U.S. IPO Plan Advanced Biomed has filed proposed terms for a $112 million U.S. IPO. The firm is developing a portfolio of cancer screening technologies for the Chinese market. ADVB has no revenue history,…
marketwatch.com Advanced Biomed sets IPO terms, which could value the biotech at up to $625 million Advanced Biomed Inc. ADVB, has set terms for its initial public offering, in which the Taiwan-based biotechnology company focused on treating cancer is looking to raise up to $125 million. The…
seekingalpha.com Advanced Biomed Begins $150 Million U.S. IPO Rollout Advanced Biomed has filed to raise $150 million in a U.S. IPO, although the final amount may vary. The Taiwan-based firm is developing various diagnostic test technologies for cancer and is focused…
proactiveinvestors.com Advanced Biomed to raise $150M in IPO Advanced Biomed, a Taiwan-based diagnostics developer, is planning to raise up to $150 million in an initial public offering (IPO). The company said it intends to list on the Nasdaq under the ticker…
